Ain Holdings Inc. (TYO:9627)
Japan
· Delayed Price · Currency is JPY 5,765.00
-135.00 (-2.29%)
Apr 28, 2026, 3:30 PM JST
Ain Holdings Revenue
Ain Holdings had revenue of 175.03B JPY in the quarter ending January 31, 2026, with 43.50% growth. This brings the company's revenue in the last twelve months to 594.86B, up 35.10% year-over-year. In the fiscal year ending April 30, 2025, Ain Holdings had annual revenue of 456.80B with 14.25% growth.
Revenue (ttm)
594.86B
Revenue Growth
+35.10%
P/S Ratio
0.34
Revenue / Employee
45.73M
Employees
13,009
Market Cap
202.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 456.80B | 56.98B | 14.25% |
| Apr 30, 2024 | 399.82B | 41.08B | 11.45% |
| Apr 30, 2023 | 358.74B | 42.50B | 13.44% |
| Apr 30, 2022 | 316.25B | 18.94B | 6.37% |
| Apr 30, 2021 | 297.31B | 4.69B | 1.60% |
| Apr 30, 2020 | Pro | Pro | Pro |
| Apr 30, 2019 | Pro | Pro | Pro |
| Apr 30, 2018 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Create SD Holdings | 483.84B |
| Kusuri No Aoki Holdings | 552.39B |
| Genky DrugStores | 211.29B |
| Sundrug | 833.92B |
| COSMOS Pharmaceutical | 1,069.50B |
| Sugi Holdings | 1,010.34B |
| Qol Holdings | 281.79B |
| Cawachi | 285.81B |